The anti-snoring devices and snoring surgery market was estimated to be USD 750 million in 2015. Some major factors stimulating the market growth are the increasing awareness about the ill effects of snoring, soaring geriatric and obese population, presence of an untapped population pool characterized with a snoring condition, and the increasing consumption of alcohol and cigarettes. The subsequent health risks associated with this condition are sleep apnea, interrupted breathing, and strain on the heart.
Anti-snoring devices and snoring surgery market, by region, 2013 - 2024 (USD Billion)
These conditions have stimulated the population to opt for treatment solutions including non-surgical appliances and surgical options, which in turn has led to the growth of the overall industry. However, factors, such as the high-cost of these surgeries, limited efficacy of the current treatments available for this condition, and unpropitious reimbursement issues are likely to hinder the growth of the anti-snoring devices and snoring surgery market. Additionally, the demerits related to the use of the non-surgical equipment, such as dry mouth, jaw discomfort, and hyper salivation serve as strong disincentives that discourage their use among the patients.
The market is segmented into anti-snoring treatment devices and snoring surgery segments. The anti-snoring devices segment includes oral appliances, nasal devices, position control devices, chin straps, tongue stabilizing devices, and expiratory positive airway pressure therapy devices.
The surgery segment includes uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. In the devices segment, nasal products including nasal strips and nasal cones are the most popular because they are easy to use and are convenient. In surgery, somnoplasty is identified as the fastest-growing segment attributable to the following factors: low cost, less painful, less invasive, and fewer complications in comparison to the conventional surgery procedures.
The key countries considered in the study are the U.S., Canada, Germany, UK, China, India, Brazil, Mexico, and South Africa. The U.S. anti-snoring devices and snoring surgery market is estimated to hold the majority of shares in the market. Factors responsible for this large share are the rising awareness regarding the detrimental effects of this condition, the presence of a large number of players in this sector, and an untapped population suffering from this condition.
As of 2015, Europe was the second-largest sector. The increasing popularity and the high adoption rate of the treatment devices have contributed to the growth of the sector in this region. Asia Pacific is expected to grow at the highest growth rate owing to the existent, large pool of untreated individuals with a snoring condition and the high level of awareness associated with this condition.
Some major competitors of the anti-snoring devices and snoring surgery market include Apnea Sciences Corporation, Pure Sleep Company, SomnoMed Ltd., Airway Management, Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, Glaxosmithkline Plc, and Meditas Ltd., among others. Agreements, collaborations, partnerships, and product launches are the major strategies, which are implemented by the leading players to attain growth in this sector.
To acquire significant shares in this sector, the companies employed certain sustainability strategies mainly involving the new product development through extensive R&D efforts. For instance, in June 2014, SomnoMed Ltd. announced the launch of two new products in the U.S., SomnoDent Herbst, and SomnoDent Fusion. These new devices are manufactured under the category of Class II medical devices and have received FDA 510(k) market clearance.
The devices are used in the treatment of chronic snoring condition as well as for mild to moderate obstructive sleep apnea cases. Additionally, in November 2015, Somnoguard AP 2 was launched by Tomed Dr. Toussaint GmbH for obstructive sleep apnea, which is a device that eases breathing through the mouth.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.